Resistance to anti-HER-2 agents: what's new

Date 05 November 2015
Event ESO Advanced Breast Cancer Third International Consensus Conference
Session Optimal management of HER-2+ ABC
Topics Breast Cancer, Metastatic
Anti-Cancer Agents & Biologic Therapy
Presenter I. E. Krop, US